Cerebellar tDCS in Children With Autism Spectrum Disorder

Description

The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.

Conditions

Autism Spectrum Disorder

Study Overview

Study Details

Study overview

The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.

Biologic Effects and Efficacy of Cerebellar tDCS in Children With Autism Spectrum Disorder

Cerebellar tDCS in Children With Autism Spectrum Disorder

Condition
Autism Spectrum Disorder
Intervention / Treatment

-

Contacts and Locations

Dallas

Children's Medical Center, Dallas, Texas, United States, 75235

Dallas

University of Texas Southwestern, Dallas, Texas, United States, 75390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 4-17 years old
  • * Diagnosed with ASD and ADOS-2
  • * IQ Score no less than 70 (1.5 Standard Deviations below the mean)
  • * Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences)
  • * Brain implants, metal implants, pacemakers, or biomedical devices
  • * Diagnosis of epilepsy
  • * Hearing or visual impairments
  • * History of brain injury
  • * Known brain abnormalities not associated with ASD

Ages Eligible for Study

4 Years to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Texas Southwestern Medical Center,

Peter Tsai, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Texas Southwestern Medical Center

Study Record Dates

2025-07-31